Skip to content

ONCOSEC MEDICAL INCORPORATED: 10-K filed 2014-10-10

What ONCOSEC MEDICAL INCORPORATED reported in its annual report filed 2014-10-10 (fiscal FY 2014): 24 published measures, 101 facts as tagged in accession 0001104659-14-071329.

This filing

Form
10-K (annual report)
Filed
2014-10-10
Fiscal period
fiscal FY 2014
Accession
0001104659-14-071329 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-07-3139,391,609USD
At 2013-07-316,509,728USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-07-311,323,551USD
At 2013-07-311,770,604USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-07-3138,068,058USD
At 2013-07-314,739,124USD
At 2012-07-314,426,265USD
At 2011-07-31-2,364,876USD
At 2010-07-31-30,059USD
At 2009-07-316,099USD
At 2008-07-3139,813USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-07-3137,852,694USD
At 2013-07-314,970,175USD
At 2012-07-315,141,509USD
At 2011-07-312,457,693USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-05-01 to 2014-07-31-3,543,357USD92
2014-02-01 to 2014-04-30-3,816,844USD89
2013-11-01 to 2014-01-31-2,600,429USD92
2013-08-01 to 2013-10-31-2,051,486USD92
2013-05-01 to 2013-07-31-1,772,615USD92
2013-02-01 to 2013-04-30-1,728,659USD89
2012-11-01 to 2013-01-31-1,621,988USD92
2012-08-01 to 2012-10-31-2,026,925USD92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-08-01 to 2014-07-31512,500USD365
2008-02-08 to 2014-07-31751,847USD2366
2012-08-01 to 2013-07-31114,550USD365
2011-08-01 to 2012-07-3154,511USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-07-31-25,363,032USD
At 2013-07-31-13,350,915USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-08-01 to 2014-07-3141,773USD365
2008-02-08 to 2014-07-3147,773USD2366
2012-08-01 to 2013-07-312,000USD365
2011-08-01 to 2012-07-312,400USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-07-31581,054USD
At 2013-07-31151,625USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-05-01 to 2014-07-31-3,543,357USD92
2013-08-01 to 2014-07-31-11,949,660USD365
2008-02-08 to 2014-07-31-26,305,340USD2366
2014-02-01 to 2014-04-30-3,816,030USD89
2013-11-01 to 2014-01-31-2,601,780USD92
2013-08-01 to 2013-10-31-1,988,493USD92
2013-05-01 to 2013-07-31-1,760,475USD92
2012-08-01 to 2013-07-31-7,064,972USD365
2013-02-01 to 2013-04-30-1,709,178USD89
2012-11-01 to 2013-01-31-1,597,843USD92
2012-08-01 to 2012-10-31-1,997,476USD92
2011-08-01 to 2012-07-31-5,527,174USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-07-3138,319,177USD
At 2013-07-315,169,687USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2008-02-08 to 2014-07-311,357USD2366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-07-311,323,551USD
At 2013-07-311,770,604USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-07-31464,693USD
At 2013-07-311,161,731USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-05-01 to 2014-07-313,543,357USD92
2014-02-01 to 2014-04-303,816,030USD89
2013-11-01 to 2014-01-312,601,780USD92
2013-08-01 to 2013-10-311,988,493USD92
2013-05-01 to 2013-07-311,760,475USD92
2013-02-01 to 2013-04-301,709,178USD89
2012-11-01 to 2013-01-311,597,843USD92
2012-08-01 to 2012-10-311,997,476USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-07-31244,631,076shares
At 2013-07-31118,014,224shares
At 2011-03-0268,480,000shares
At 2011-02-282,140,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-07-3156,081,475USD
At 2013-07-3111,467,139USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-07-31723,367USD
At 2013-07-31225,347USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-07-31142,313USD
At 2013-07-3173,722USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-07-3126,685USD
At 2013-07-3126,685USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-05-01 to 2014-07-31-3,543,357USD92
2013-08-01 to 2014-07-31-12,012,117USD365
2008-02-08 to 2014-07-31-25,363,032USD2366
2014-02-01 to 2014-04-30-3,816,844USD89
2013-11-01 to 2014-01-31-2,600,429USD92
2013-08-01 to 2013-10-31-2,051,486USD92
2013-05-01 to 2013-07-31-1,772,615USD92
2012-08-01 to 2013-07-31-7,150,187USD365
2013-02-01 to 2013-04-30-1,728,659USD89
2012-11-01 to 2013-01-31-1,621,988USD92
2012-08-01 to 2012-10-31-2,026,925USD92
2011-08-01 to 2012-07-31-2,364,852USD366
2010-08-01 to 2011-07-31-3,758,817USD365
2009-08-01 to 2010-07-31-36,158USD365
2008-08-01 to 2009-07-31-33,714USD365
2008-02-09 to 2008-07-31-7,187USD174

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-08-01 to 2014-07-316,153,313USD365
2008-02-08 to 2014-07-3114,395,945USD2366
2012-08-01 to 2013-07-313,905,763USD365
2011-08-01 to 2012-07-313,158,693USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-08-01 to 2014-07-3183,000USD365
2012-08-01 to 2013-07-3140,000USD365
2011-08-01 to 2012-07-3135,000USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-08-01 to 2014-07-31780,110USD365
2008-02-08 to 2014-07-312,485,256USD2366
2012-08-01 to 2013-07-31736,875USD365
2011-08-01 to 2012-07-31717,450USD366

Inspect the source

Entity
ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
Captured
SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))